Roots Analysis

FEBRUARY 23, 2022

Further, NGS library preparation kits offer several benefits, such as low requirement of starting material, generation of longer RNA / DNA sequences and production of superior quality nucleotide libraries, thereby, catering to existing unmet needs of the research domain. Next Generation Sequencing (NGS) Library Preparation Kits.

Genetics 52

Genetics DNA RNA Reagent 52

XTalks

AUGUST 18, 2020

An important feature of the test that contributes to its reduced cost is the fact that sample processing does not require a separate nucleic acid (RNA) extraction step. This is significant because shortages of RNA extraction kits have been a recurrent issue since the beginning of the pandemic.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

Roots Analysis

AUGUST 15, 2023

Further, other improvements, including efficient production cycles, use of low-cost reagents and development of purified component platforms, have made cell free biomanufacturing a preferred option for synthesis of various types of biologics and small molecules.

Protein 52

Protein In-Vitro Production Reagent 52

Pharmaceutical Technology

FEBRUARY 15, 2023

The swift development and deployment of messenger-RNA (mRNA) vaccines against the SARS-CoV-2 virus during the COVID-19 crisis has catapulted the pharmaceuticals industry into a new paradigm. RNA has the potential to underpin breakthrough treatments for a wide variety of diseases, including many cancers, and transform medicine as we know it.

Bioassay 130

Bioassay Development RNA Drugs 130

Drug Discovery World

DECEMBER 28, 2022

Gyrolab Human Cytokine Kit Reagents are the first in a range of new biomarker kits from Gyros Protein Technologies. . They include five single analyte biomarker kit reagents for the quantification of human inflammatory cytokines: human TNF-a, IFN-gamma, IL-6, IL-10 and IL-4. . Gyrolab Biomarker Kits – Gyros Protein Technologies .

Production 97

Production Reagent Drugs Life Science 97

Roots Analysis

FEBRUARY 13, 2023

However, because of such operational and technical challenges associated with the production of RNA-based products innovators in the biopharmaceutical industry are increasingly relying on the contract service providers.

Manufacturing 52

Manufacturing Drug Delivery Systems Genetic Engineering RNA 52

Drug Discovery World

DECEMBER 23, 2022

GenScript USA has expanded its global current Good Manufacturing Practices (cGMP) single-guide RNA (sgRNA) manufacturing capabilities to meet the growing demand for cell and gene therapies. . The 400,000 square-foot cGMP facility enables gene and cell therapy R&D programmes to advance IND filings and clinical trials.

Gene Therapy 52

Gene Therapy Gene Reagent Clinical Trials 52

The Pharma Data

MARCH 20, 2021

The Challenge: The demands of many labs simultaneously beginning COVID-19 screening programs are leading to a scarcity of resources like pipette tips and reagents. delays where reagents are in. Biogazelle, an innovative bioanalytical services company offering RNA and. In the examples below, we. highlight the experiences of.

Reagent 52

Reagent RNA Bioinformatics Medicine 52

Drug Discovery World

JULY 18, 2023

Nucleic acid-based diagnostics, which typically require PCR reagents and laboratory equipment, are crucial for identifying, treating, and preventing common infectious diseases. CRISPR diagnostics have successfully detected various pathogens, including RNA viruses (eg. Herpesviridae, Polyomaviridae, and Papillomaviridae), bacteria (e.g.,

DNA 98

DNA Genome Genomics RNA 98

pharmaphorum

FEBRUARY 3, 2021

This can be partly attributed to the reagents and delivery modalities that were available at the time of the trial start in 2016, leading to low editing efficiency at the target loci. However, the number of CAR-T cells with all four genes correctly targeted was low.

Gene Editing 98

Gene Editing Gene DNA Engineer 98

Roots Analysis

AUGUST 28, 2022

As a result, industry and non-industry stakeholders, are on the lookout for advanced platforms that can simultaneously capture the arrangement of multiple biomolecules (DNA, RNA, proteins and others) with single-cell or subcellular resolution.

Genome 52

Genome Genomics RNA Genome Project 52

Drug Discovery World

NOVEMBER 30, 2023

coli expression systems and is using high-throughput expression pipelines to screen constructs for optimal expression to generate protein and cellular reagents. The Absolute Antibody team was available to discuss custom services, as well as the company’s comprehensive antibody reagent catalogue.

Antibody 59

Antibody Protein Engineer In-Vivo 59

Drug Discovery World

JUNE 6, 2023

The new RNA-based sequencing offering for solid tumours uses a single RNA/TNA input sample and provides a scalable, easy-to-use solution that offers time, resource and cost savings for researchers. Juarez said: “Ultimately, it’s a single workflow and so that streamlines us. It’s a 1.5

Protein 52

Protein DNA RNA Research 52

Drug Discovery World

DECEMBER 15, 2022

Prime editing, while also employing a single strand nick, expands this scope to all 12 possible changes using a more complex prime editing guide RNA (pegRNA). DNA targeting specificity of RNA-guided Cas9 nucleases . Prime editing can be used for base swapping, as well as for targeted small insertions and deletions. References.

Gene Editing 52

Gene Editing Gene In-Vivo Genome 52

XTalks

APRIL 22, 2022

In addition, Dr. Olsson explained that cell sorting by flow cytometry can be used in the clinical laboratory to isolate a specific cell type of interest for analysis by PCR or single cell RNA sequencing. What is a Receptor Occupancy Assay? In addition, more than one type of assay may be used, depending on the question being investigated.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Antibody 98

Drug Discovery World

OCTOBER 20, 2022

used conventional flow cytometry analysis and FACS (fluorescence-activated cell sorting) to validate a pan-CAF marker along with CAF subpopulation-specific markers identified using single-cell RNA sequencing 3. Elyada et al. This strategy identified a novel class of antigen presenting CAFs that were able to interact with CD4+ T cells3.

Antibody 52

Antibody In-Vivo Life Science Development 52